http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014172315-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_804b31b5fe423ff5ee0d8a914da2dd8f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2014-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93c43d166e937ab3f5b2c25ea59657bd |
| publicationDate | 2014-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2014172315-A2 |
| titleOfInvention | Methods of treating proliferative disorders |
| abstract | The invention is based on the discovery that elevated levels of oxidative stress shortly after administration of chemotherapeutic or radiation therapy in subjects having proliferative disorders is indicative of sensitivity to the administered chemotherapeutic or radiation therapy. Consequently, measurement of oxidative stress biomarker levels can inform whether a particular chemotherapeutic or radiation therapy is likely to be efficacious in treating a proliferative disorder before prolonged exposure to the therapy. This information allows a subject to avoid unnecessary and otherwise dangerous therapies and increases the likelihood that a selected therapeutic course will ultimately lead to treatment of a particular proliferative disorder. |
| priorityDate | 2013-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1473.